NL-OMON41924尚未招募不适用
THE EFFECT OF NIACINAMIDE SUPPLEMENTATION ON PHOSPHATE CONCENTATIONS IN DIALYSIS PATIENTS. - the DiaNia-study
Ziekenhuis Gelderse Vallei0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Hemodialysis patients
- •- Adults (* 18 year)
- •- Stable dialysis state (at least 6 months hemodialysis ) as measured at baseline
排除标准
- •- Severely malnourished patients as diagnosed by the dietitian
- •- Patients who dialyse at night in-hospital
- •- Language barrier
研究者
相似试验
已完成
2 期
Treatment hyperphosphatemia in hemodialysis patienthyperphosphatemia in hemodialysis.Extracorporeal dialysisIRCT201011295275N1Vice chancellor for research, Tabriz University of Medical Sciences and Health Services70
已完成
不适用
Effects of nefopam on catheter-related bladder discomfortKCT0002758Kyungpook National University Medical Center54
尚未招募
Unknown
Effect of nicotinamide riboside supplementation in dilated cardiomyopathy patients to CERP, Chromadex Inc. USACTRI/2023/04/051385Chromadex Inc. USA
进行中（未招募）
1 期
Efficacy and tolerability of nicotinamide as add-on therapy compared to placebo in dialysis-dependent patients with elevated phosphat levelDialysis-dependent patients with hyperphosphatemiaMedDRA version: 17.0Level: LLTClassification code 10020712Term: HyperphosphatemiaSystem Organ Class: 100000004861EUCTR2013-000488-95-PLMEDICE Arzneimittel Pütter GmbH & Co. KG700
进行中（未招募）
1 期
Efficacy and tolerability of nicotinamide as add-on therapy compared to placebo in dialysis-dependent patients with elevated phosphat levelDialysis-dependent patients with hyperphosphatemiaMedDRA version: 19.0Level: LLTClassification code 10020712Term: HyperphosphatemiaSystem Organ Class: 100000004861EUCTR2013-000488-95-ATMEDICE Arzneimittel Pütter GmbH & Co. KG700